The Diabetic Gastroparesis Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Diabetic Gastroparesis Treatment Market:
https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report
According to The Business Research Company’s Diabetic Gastroparesis Treatment Global Market Report 2024, The diabetic gastroparesis treatment market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing diabetes prevalence, limited treatment options, rising awareness and diagnosis, healthcare infrastructure development.
The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, growing diabetic population, increased research and development, shift in regulatory landscape. Major trends in the forecast period include technological innovations in treatments, emergence of novel therapies, focus on symptom management, telemedicine and remote monitoring, gut microbiome interventions.
The increasing prevalence of diabetes is expected to propel the growth of the diabetic gastroparesis treatment market going forward. The prevalence of diabetes refers to the proportion or percentage of the population that has been diagnosed with diabetes at a specific point in time. The use of diabetic gastroparesis treatment is primarily aimed at managing the symptoms and complications associated with this condition, which is a common complication of diabetes. For instance, in April 2023, according to a report published by The British Diabetic Association, a UK-based diabetes charity, 4.3 million individuals in the UK have diabetes and live with it. Further, more than 2.4 million people in the UK are at high risk of acquiring type 2 diabetes, and registration numbers for 2021–22 are 148,951. Therefore, the increasing prevalence of diabetes is driving the growth of the diabetic gastroparesis treatment market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12580&type=smp
The diabetic gastroparesis treatment market covered in this report is segmented –
1) By Treatment: Medication, Surgery
2) By Route Of Administration: Oral, Injectables
3) By Indication: Compensated Gastroparesis, Gastric Failure
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
The rising number of surgical procedures is expected to propel the growth of the diabetic gastroparesis treatment market going forward. Surgery refers to a medical specialty and branch of medicine that involves the treatment of diseases, injuries, or conditions through operative procedures. Surgical procedures in diabetic patients that have caused post-surgical gastroparesis include Nissen fundoplication, gastrectomy, gastric bypass surgery, pancreatectomy, vagotomy, and cholecystectomy by injuring the vague nerve that coordinates food movement through the digestive tract. For instance, in April 2022, according to the Aesthetic Society, a US-based industry organization of plastic surgeons, surgical aesthetic procedures increased by 54% in 2021 as compared to 2020. On average, a surgeon performed 320 procedures in 2021, up from 220 procedures in 2020. Therefore, the rising number of surgical procedures drives the diabetic gastroparesis treatment market.
The diabetic gastroparesis treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
